XOMA soars 33% after announcing the discovery of two new classes of fully human monoclonal...

|About: XOMA Corporation (XOMA)|By:, SA News Editor
XOMA soars 33% after announcing the discovery of two new classes of fully human monoclonal antibodies at the American Diabetes Association 71st Scientific Sessions in San Diego.